About B. Silber
Form D filings for Reiley Pharmaceuticals from 2014 to 2024 list B. Silber as director.
B. Silber first appears on SEC filings in 2014.
Experience
This experience comes from SEC filings. The years are when the filings name B. Silber in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people B. Silber works with at each company, as listed on that company's latest Form D.
Reiley Pharmaceuticals, Inc. · Form D, Jun 5, 2024